Implementation of Lung Cancer Screening: Proceedings of a Workshop | Agenda Bookshop Skip to content
Black Friday Sale Now On! | Buy 3 Get 1 Free on all books | Instore & Online.
Black Friday Sale Now On! | Buy 3 Get 1 Free on all books | Instore & Online.
A01=and Medicine
A01=Board on Health Care Services
A01=Engineering
A01=Health and Medicine Division
A01=National Academies of Sciences
A01=National Cancer Policy Forum
Age Group_Uncategorized
Age Group_Uncategorized
Author_and Medicine
Author_Board on Health Care Services
Author_Engineering
Author_Health and Medicine Division
Author_National Academies of Sciences
Author_National Cancer Policy Forum
automatic-update
B01=Erin Balogh
B01=Margie Patlak
B01=Sharyl J. Nass
Category1=Non-Fiction
Category=MBP
Category=MJCL
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€20 to €50
PS=Active
softlaunch

Implementation of Lung Cancer Screening: Proceedings of a Workshop

The public health burden from lung cancer is substantial: it is the second most commonly diagnosed cancer and the leading cause of cancer-related deaths in the United States. Given the individual and population health burden of lung cancer, especially when it is diagnosed at later stages, there has been a push to develop and implement screening strategies for early detection. However, many factors need to be considered for broad implementation of lung cancer screening in clinical practice. Effective implementation will entail understanding the balance of potential benefits and harms of lung cancer screening, defining and reaching eligible populations, addressing health disparities, and many more considerations.

In recognition of the substantial challenges to developing effective lung cancer screening programs in clinical practice, the National Academies of Sciences, Engineering, and Medicine held a workshop in June 2016. At the workshop, experts described the current evidence base for lung cancer screening, the current challenges of implementation, and opportunities to overcome them. Workshop participants also explored capacity and access issues; best practices for screening programs; assessment of patient outcomes, quality, and value in lung cancer screening; and research needs that could improve implementation efforts. This publication summarizes the presentations and discussions from the workshop.

Table of Contents
  • Front Matter
  • Proceedings of a Workshop
  • Appendix A: Statement of Task
  • Appendix B: Workshop Agenda
  • Appendix C: Glossary
See more
Current price €49.39
Original price €51.99
Save 5%
A01=and MedicineA01=Board on Health Care ServicesA01=EngineeringA01=Health and Medicine DivisionA01=National Academies of SciencesA01=National Cancer Policy ForumAge Group_UncategorizedAuthor_and MedicineAuthor_Board on Health Care ServicesAuthor_EngineeringAuthor_Health and Medicine DivisionAuthor_National Academies of SciencesAuthor_National Cancer Policy Forumautomatic-updateB01=Erin BaloghB01=Margie PatlakB01=Sharyl J. NassCategory1=Non-FictionCategory=MBPCategory=MJCLCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€20 to €50PS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Dimensions: 152 x 229mm
  • Publication Date: 27 Jul 2017
  • Publisher: National Academies Press
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9780309451321

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept